AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 23463651
Drug: Combination training
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination training (ATRT)
Trial: 18580879
Drug: Domperidone (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone (0.3 mg/kg per os at the eighth and sixteenth hour)
Trial: 8707471
Drug: Treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment group (stressed students with LD)
Trial: 8707471
Drug: Treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment group (regular education students)
Trial: 1848385
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin (Logiparin) 50 IU anti-Xa per kilo body weight once daily
Trial: 6754634
Drug: Labetalol (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Labetalol (300 mg)
Trial: 31471834
Drug: Chinese medicine
RxNorm normalized name: BUTYLENE GLYCOL 48 g in 240 mL CUTANEOUS TAPE [QIZHOUGUAI Chinese medicine patch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese medicine (CM) therapy for more than 6 months
Trial: 31471834
Drug: Chinese medicine
RxNorm normalized name: BUTYLENE GLYCOL 48 g in 240 mL CUTANEOUS TAPE [QIZHOUGUAI Chinese medicine patch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese medicine (CM) therapy for 6-12 months
Trial: 31471834
Drug: Chinese medicine
RxNorm normalized name: BUTYLENE GLYCOL 48 g in 240 mL CUTANEOUS TAPE [QIZHOUGUAI Chinese medicine patch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese medicine (CM) therapy for 12-18 months
Trial: 31471834
Drug: Chinese medicine
RxNorm normalized name: BUTYLENE GLYCOL 48 g in 240 mL CUTANEOUS TAPE [QIZHOUGUAI Chinese medicine patch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese medicine (CM) therapy for >24 months
Trial: 22978101
Drug: Chinese medicine
RxNorm normalized name: BUTYLENE GLYCOL 48 g in 240 mL CUTANEOUS TAPE [QIZHOUGUAI Chinese medicine patch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese medicine (CM) therapy
Trial: 27965485
Drug: 20 mL
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mL of 2 to 4°C cold saline irrigated during 5 minutes using EndoVac
Trial: 27965485
Drug: 20 mL
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mL of room temperature saline irrigated during 5 minutes using EndoVac
Trial: 25214768
Drug: Test drug
RxNorm normalized name: URINE TEST DRUGS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test drug (300 mg gabapentin)
Trial: 25214768
Drug: Reference drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference drug (300 mg gabapentin)
Trial: 17389704
Drug: MMI 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MMI 30 mg/d
Trial: 17389704
Drug: PTU 300
RxNorm normalized name: Propylthiouracil
DrugBank: Propylthiouracil (DB00550)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PTU 300 mg/d
Trial: 17389704
Drug: MMI 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MMI 15 mg/d
Trial: 12789956
Drug: Braun Oral‐B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Braun Oral‐B Kids' Power Toothbrush (D10) for 2 months
Trial: 12789956
Drug: Braun Oral‐B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Braun Oral‐B Kids' Power Toothbrush (D10)
Trial: 8543722
Drug: Psychodynamic-interpersonal (PI)
RxNorm normalized name: camphor
DrugBank: Camphor (DB01744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Psychodynamic-interpersonal (PI) therapy
Trial: 8543722
Drug: Cognitive-behavioral (CB)
RxNorm normalized name: BroveX CB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral (CB) therapy
Trial: 7617806
Drug: Moclobemide (300‐600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moclobemide (300‐600 mg daily)
Trial: 7617806
Drug: Fluoxetine (20‐40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (20‐40 mg daily)
Trial: 7617806
Drug: Moclobemide (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moclobemide (600 mg daily after doubling dosage for non-responders)
Trial: 2571689
Drug: Intracerebroventricular bethanechol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracerebroventricular bethanechol chloride infusion
Trial: 19030908
Drug: Fermented milk
RxNorm normalized name: MILK
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fermented milk (f-milk) without supplements
Trial: 11101198
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg mibefradil per day
Trial: 11101198
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg mibefradil per day
Trial: 11101198
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg mibefradil per day
Trial: 8992903
Drug: Cimetidine 400
RxNorm normalized name: cimetidine 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 400 mg IV 30 min before anaesthesia
Trial: 1303408
Drug: Conventional management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional management and 4 sessions of hyperbaric oxygen therapy
Trial: 29898848
Drug: Apixaban (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apixaban (5 mg bid or 2.5 mg bid if combined with antiplatelet therapy)
Trial: 29898848
Drug: Standard of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard of care (SOC Group) including VKA therapy or antiplatelet therapy (single or dual)
Trial: 19514478
Drug: Cages (titanium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cages (titanium interbody implants)
Trial: 9431711
Drug: Topical 3%
RxNorm normalized name: sulfur topical 3% topical soap
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 3% diclofenac in 2.5% hyaluronic acid gel
Trial: 9431711
Drug: Gel containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gel containing 2.5% hyaluronic acid alone
Trial: 29111905
Drug: 100 mg/day
RxNorm normalized name: infigratinib phosphate 100 mg/day (100 mg x 1) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg/day CoQ10 supplements
Trial: 25980298
Drug: Rituximab in
RxNorm normalized name: rituximab Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rituximab in combination with methotrexate
Trial: 22817868
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg of inhaled Salvinorin A
Trial: 22817868
Drug: 12 mg
RxNorm normalized name: pectin 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 mg of inhaled Salvinorin A
Trial: 22817868
Drug: 0 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg of inhaled Salvinorin A (control)
Trial: 18832343
Drug: Tolterodine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolterodine (4 mg/d)
Trial: 18832343
Drug: Darifenacin (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darifenacin (15 mg/d)
Trial: 12810503
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin type A (BTX‐A) treatment (50 U per axilla)
Trial: 12810503
Drug: Quality of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quality of life parameters and satisfaction after BTX‐A treatments
Trial: 8780660
Drug: 1-unit donation
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 1-unit donation (206 +/- 10 mL)
Trial: 8780660
Drug: 2-unit donation
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 2-unit donation (414 +/- 21 mL)
Trial: 28624340
Drug: Denosumab (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denosumab (60 mg every 6 months)
Trial: 18308653
Drug: Alendronate (70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate (70 mg weekly)
Trial: 17485150
Drug: recombinant subunit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: recombinant subunit gp350 Epstein-Barr virus vaccine
Trial: 11566144
Drug: Opioid blockade
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Opioid blockade with naltrexone (single oral dose)
Trial: 9861567
Drug: Amikacin single
RxNorm normalized name: Amikacin
DrugBank: Amikacin (DB00479)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Amikacin single daily dosage (20 mg/kg)
Trial: 9861567
Drug: Amikacin twice
RxNorm normalized name: Amikacin
DrugBank: Amikacin (DB00479)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Amikacin twice daily dosage (20 mg/kg)
Trial: 7946862
Drug: Midazolam (0.06
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.06 mg kg‐1)
Trial: 7946862
Drug: Propofol (2.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (2.2 mg kg‐1 h‐1)
Trial: 7946862
Drug: No sedative
RxNorm normalized name: MedActive Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No sedative drug (group ND)
Trial: 29446174
Drug: Family-based treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Family-based treatment for bulimia nervosa (FBT-BN)
Trial: 29446174
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral therapy for adolescents (CBT-A)
Trial: 25028357
Drug: IVB (1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVB (1.25 mg)
Trial: 17087779
Drug: betaine 100
RxNorm normalized name: betaine 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: betaine 100 mg kg(‐1) day(‐1)
Trial: 11878729
Drug: Dexamethasone 8
RxNorm normalized name: dexamethasone 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 8 mg plus Ondansetron 4 mg
Trial: 10195517
Drug: Dextromethorphan 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextromethorphan 0.5 mg/kg p.o. 1 hour before surgery
Trial: 10195517
Drug: Dextromethorphan 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextromethorphan 1.0 mg/kg p.o. 1 hour before surgery
Trial: 2323832
Drug: High doses
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High doses of birch pollen
Trial: 2323832
Drug: Lower doses
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower doses of birch pollen (about half the effective dose)
Trial: 6985760
Drug: Intermittent sequential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent sequential pneumatic compression (six chambers) at pressures of 35, 30, and 20 mm Hg for 12 seconds
Trial: 6985760
Drug: Sequential compression
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential compression device
Trial: 6985760
Drug: Small-dose subcutaneous
RxNorm normalized name: smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Solution [ACAM2000]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Small-dose subcutaneous heparin
Trial: 12593177
Drug: Inhaled steroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled steroids
Trial: 15540912
Drug: Ceftriaxone, 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone, 1 g given twice a day until occurrence of meningitis or at least 5 days after trauma
Trial: 15540912
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no antibiotic medication)
Trial: 9041304
Drug: 1500 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1500 mg/kg RSVIG
Trial: 8174569
Drug: Once-daily dosage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily dosage of 60 mg isosorbide-5-mononitrate
Trial: 8174569
Drug: Twice-daily dosage
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily dosage of 60 mg isosorbide-5-mononitrate
Trial: 3148071
Drug: Oral betaine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral betaine, 3 g b.i.d
Trial: 28654365
Drug: Protocol-assigned endocrine
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Protocol-assigned endocrine therapy
Trial: 17598141
Drug: Self-management therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-management therapy (n = 51)
Trial: 17598141
Drug: Active-control therapy
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active-control therapy (n = 50)
Trial: 9436336
Drug: Senna (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Senna (0.4 mL daily)
Trial: 9436336
Drug: Lactulose (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactulose (15 mL daily)
Trial: 2520620
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg ranitidine twice daily (b.d.)
Trial: 2520620
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg ranitidine four times daily (q.d.s.)
Trial: 27798417
Drug: Other Angiotensin-converting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other Angiotensin-converting enzyme inhibitors
Trial: 23933232
Drug: Capsaicin 8%
RxNorm normalized name: CAPSAICIN 8% PATCH KIT,4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsaicin 8% patch application (all sites)
Trial: 16886330
Drug: Antiparasitic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiparasitic treatment with metronidazole
Trial: 8471832
Drug: Pindolol 10
RxNorm normalized name: pindolol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol 10 mg
Trial: 29716637
Drug: Ketamine (subdissociative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (subdissociative dose)
Trial: 25037206
Drug: Naltrexone 50-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone 50-100 mg/d (flexible dosing)
Trial: 22700860
Drug: Prednisone (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (1.5 mg/kg/day for 2 weeks followed by 0.75 mg/kg/day for 2 weeks)
Trial: 20020107
Drug: 0.5 per
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 per thousand alcohol administration
Trial: 17627745
Drug: Transdermal testosterone
RxNorm normalized name: testosterone Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal testosterone treatment (300 mcg/day)
Trial: 9755360
Drug: mCPP (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mCPP (0.5 mg/kg orally)
Trial: 3925486
Drug: Naloxone (1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (1.2 mg IV)
Trial: 4917915
Drug: Monovalent inactivated
RxNorm normalized name: diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tdvax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monovalent inactivated vaccine of the Hong Kong strain of influenza A virus
Trial: 4917915
Drug: Polyvalent vaccine
RxNorm normalized name: pneumococcal 23-polyvalent vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyvalent vaccine containing only pre‐1968 Asian viruses
Trial: 4917915
Drug: Intranasal spray
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal spray of the Hong Kong vaccine in addition to injected Asian vaccine
Trial: 29410606
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg lemon verbena extract once daily
Trial: 26429636
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose CT screening
Trial: 23633626
Drug: Neural Tissue
RxNorm normalized name: tissue respiratory factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neural Tissue Management (NTM) - brief education, manual therapy, and nerve gliding exercises for 4 treatments over 2 weeks
Trial: 17313010
Drug: Simple electroacupuncture
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simple electroacupuncture or exercise therapy
Trial: 9471669
Drug: Ranitidine, 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine, 150 mg at bedtime for 12 months
Trial: 7920941
Drug: NO and
RxNorm normalized name: GLYCERYL MONO AND DICAPRYLOCAPRATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NO and Pg E1 combination
Trial: 3883738
Drug: Molsidomine 4
RxNorm normalized name: molsidomine 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Molsidomine 4 mg orally (single dose)
Trial: 3883738
Drug: Molsidomine 4
RxNorm normalized name: molsidomine 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Molsidomine 4 mg orally (long-term treatment, 3 times daily for 3 weeks)
Trial: 3883738
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy with digitalis and diuretics (Control)
Trial: 30184031
Drug: Oral vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vitamin D (50,000 U)
Trial: 25420552
Drug: Whey protein
RxNorm normalized name: Whey protein
DrugBank: Whey (DB18685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whey protein hydrolysate plus sucrose (0.4 g · kg(‐1) each)
Trial: 25420552
Drug: Isocaloric sucrose
RxNorm normalized name: Sucrose
DrugBank: Sucrose (DB02772)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isocaloric sucrose control (0.8 g · kg(‐1))
Trial: 25420552
Drug: Whey protein
RxNorm normalized name: Whey protein
DrugBank: Whey (DB18685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whey protein hydrolysate and sucrose (0.4 + 0.4 g · kg(‐1) · h(‐1)) with immediate ingestion
Trial: 25420552
Drug: Whey protein
RxNorm normalized name: Whey protein
DrugBank: Whey (DB18685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whey protein hydrolysate and sucrose (0.4 + 0.4 g · kg(‐1) · h(‐1)) with overnight ingestion
Trial: 10624069
Drug: Esmolol (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esmolol (500 micrograms/kg bolus followed by infusion of up to 100 micrograms/kg/min)
Trial: 26598418
Drug: No sedative
RxNorm normalized name: MedActive Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No sedative treatment
Trial: 29785878
Drug: FFR-guided PCI
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FFR-guided PCI plus medical therapy
Trial: 22484664
Drug: Nitrite therapy
RxNorm normalized name: Nitrite
DrugBank: Nitrite (DB12529)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrite therapy
Trial: 22484664
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose nitrite infusion
Trial: 8241229
Drug: Deflazacort, 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deflazacort, 1.5 mg/kg/day, tapered to 0.25 mg/kg/day after 2-3 weeks
Trial: 8241229
Drug: Prednisone, 1
RxNorm normalized name: PredniSONE, 1 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone, 1 mg/kg/day, tapered to 0.15 mg/kg/day after 2-3 weeks
Trial: 31259628
Drug: Reduced in-treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reduced in-treatment systolic blood pressure (SBP)
Trial: 31259628
Drug: Reduction in
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reduction in in-treatment SBP
Trial: 26063441
Drug: Propranolol (beta-blocker)
RxNorm normalized name: beta-Propranolol
DrugBank: Propranolol (DB00571)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propranolol (beta-blocker) administered in a double-blind, placebo-controlled study
Trial: 16523267
Drug: Liquorice gel
RxNorm normalized name: Liquorice
DrugBank: Licorice (DB10675)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liquorice gel (control + 2.5% liquorice extract)
Trial: 16523267
Drug: Control gel
RxNorm normalized name: SALICYLIC ACID 20 mg in 1 mL TOPICAL GEL [Walgreens Acne Control Gel]
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control gel (8% acid‐hydrolyzed corn starch, 25% maltitol syrup, water)
Trial: 16523267
Drug: Liquorice gel
RxNorm normalized name: Liquorice
DrugBank: Licorice (DB10675)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liquorice gel
Trial: 12602644
Drug: Co-occurring substance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-occurring substance abuse, treatment nonadherence, and outpatient services intensity
Trial: 7903326
Drug: ipsapirone 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ipsapirone 5 mg t.i.d.
Trial: 7903326
Drug: ipsapirone 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ipsapirone 10 mg t.i.d.
Trial: 7903326
Drug: diazepam 5
RxNorm normalized name: diazepam 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diazepam 5 mg t.i.d.
Trial: 3936946
Drug: Chemotherapy (Mitomycin‐C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (Mitomycin‐C + FT 207)
Trial: 26701357
Drug: BD FlowSmart
RxNorm normalized name: BD-111
DrugBank: BD-111 (DB18247)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BD FlowSmart infusion set
Trial: 22349482
Drug: Caffeine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (5 mg/kg ingested on 2 separate days)
Trial: 17342402
Drug: Empiric PPI
RxNorm normalized name: aspirin / codeine phosphate Oral Tablet [Empirin with Codeine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empiric PPI treatment
Trial: 8195335
Drug: Human biosynthetic
RxNorm normalized name: Proinsulin biosynthetic human
DrugBank: Proinsulin human (DB17875)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human biosynthetic growth hormone (HGH; 12 IU/day)